Document is current
Any future updates will be listed below
-
Authors
Adorjan, Kristina
Martins-de-Souza, Daniel
Walter, Martin
- License Information
-
More Information
Article History
First Online: 12 September 2024
Declarations
:
: KA, DMS have no conflicts of interests. MW is a member of the following advisory boards and has given presentations to the following companies: Bayer AG, Germany; Boehringer Ingelheim, Germany; and Biologische Heilmittel Heel GmbH, Germany. Unrelated to this investigation, M.W. has conducted studies with institutional research support from HEEL and Janssen Pharmaceutical Research for a clinical trial (IIT) on ketamine in patients with MDD. From the companies mentioned above, M.W. did not receive any financial compensation. All other authors report no biomedical financial interests or other potential conflicts of interest that are relevant to the content of this article.
Free to read: This content has been made available to all.
